[Inhibition of catabolism of liver phospholipids by 2-(4' methyl piperazino 1' methyl)1-3 diaza fluoranthene oxide 1 (AC-3579)].
D000818:Animals; D006529:Hepatomegaly; D006993:Hypnotics and Sedatives / Q000494:pharmacology*; D008099:Liver / Q000032:analysis / Q000187:drug effects* / Q000378:metabolism; D008297:Male; D009929:Organ Size; D010710:Phosphates / Q000008:administration & dosage; D010743:Phospholipids / Q000097:blood / Q000378:metabolism*; D010761:Phosphorus Radioisotopes; D010879:Piperazines / Q000494:pharmacology*; D051381:Rats
D006993:Hypnotics and Sedatives; D010710:Phosphates; D010743:Phospholipids; D010761:Phosphorus Radioisotopes; D010879:Piperazines
Inhibition du catabolisme des phospholipides hépatiques par le 2-(4' méthyl pipérazino l'méthyl) 1-3 diaza fluoranthène oxyde 1, AC-3579